Med-X (MXRX) Files Third S-1/A, Sets Nasdaq IPO at 16.25 Million Shares
As seen on the 24/7 Wall St. homepage on November 5, 2026.
Third S-1/A sets the Med-X offering at 16.25 million shares
Med-X is now three amendments deep into its Nasdaq listing attempt, with 16,248,842 shares on the table and Maxim Group running the book. Pricing terms are the last missing piece before this natural pesticide maker trades.
Continue ReadingShow less
Med-X, Inc. has now filed three successive amendments to its S-1 registration statement as it works toward a Nasdaq listing, with each amendment marking another step through SEC review.
The offering is set at 16,248,842 shares with Maxim Group running the book, but no pricing range has been filed, so the cost per share and total deal size remain unknown.
Sponsored
Med-X describes itself as a natural pesticide maker, and pricing is the single remaining hurdle before investors can assess valuation and decide whether to participate.
The third amendment narrows the gap between filing and trading, and once a price range appears the IPO calendar clock effectively starts.
Mentioned: MXRX